• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

GAiT.Global

The Global Alliance for iPSC Therapies

  • About GAiT
    • About GAiT
    • Sponsors
      • NYSCF
      • KHiB
      • CCRM
      • INSERM / Cithera /INGESTEM
      • HKU
      • CGT
    • Support Us
  • News & Events
  • Publications
  • Workshops
  • Quality Assessment Rounds
  • Directories
  • Clinical Database
  • Portal Login
You are here: Home / Board Members / CGT

CGT

cgt

A centre of excellence

The Cell and Gene Therapy Catapult is a centre of excellence in innovation, with the core purpose of building a world-leading cell and gene therapy sector in the UK as a key part of a global industry. Supported by Innovate UK, our mission is to drive the growth of the industry by helping cell and gene therapy organisations across the world translate early stage research into commercially viable and investable therapies. We are based on the 12th floor of Guy’s Hospital in central London, with over 120 cell and gene therapy experts, state-of-the art development and viral vector laboratories. We are also building a £55m large-scale GMP manufacturing centre to help bring cell and gene therapies to market in the UK and internationally.

Our vision

The Cell and Gene Therapy Catapult vision is for the UK to be a global leader in the development, delivery and commercialisation of cell and gene therapy. Where businesses can start, grow and confidently develop cell and gene therapies, delivering them to patients rapidly, efficiently and effectively.

Our mission

Our mission is to grow the industry in the UK to substantial and sustainable levels by:

  • taking products into clinical trial, de-risking them for further investment;
  • providing clinical expertise and access to NHS clinical partners;
  • providing technical expertise and infrastructure to ensure products can be made to GMP and delivered cost effectively;
  • providing regulatory expertise to ensure that products can get to the clinic safely, in the shortest amount of time;
  • providing opportunities for collaboration, both nationally and globally; and
  • providing access to business expertise, grants and investment finance so that commercially viable products are progressed and investable propositions are generated.

Primary Sidebar

Search Users

GAiT News

IPSCtherapies avatar; GAiT @IPSCtherapies ·
7h 1526965177769508864

Speaker line up for NYSCF's annual conference 18-19th October 2022 has been announced.

Image for twitter card

2022 NYSCF Conference

The NYSCF Conference is the premier translational stem cell research conference. Held annually for the past 16 years...

conference.nyscf.org

Reply on Twitter 1526965177769508864 Retweet on Twitter 1526965177769508864 0 Like on Twitter 1526965177769508864 1 Twitter 1526965177769508864
IPSCtherapies avatar; GAiT @IPSCtherapies ·
6 May 1522493868750553091

Members of GAiT's industrial liaison committee @FeyeuxMaxime and @AndyG_0 (representing @treefrogtx and @STEMCELLTech respectively) speak with GAiT Director & @CCRM CEO @MichaelMay5 at #ISCT2022

Image for the Tweet beginning: Members of GAiT's industrial liaison Twitter feed image.
Reply on Twitter 1522493868750553091 Retweet on Twitter 1522493868750553091 1 Like on Twitter 1522493868750553091 7 Twitter 1522493868750553091
IPSCtherapies avatar; GAiT @IPSCtherapies ·
5 May 1522258567692177409

Lots of discussion of what constitutes 'suitable donor material' for iPSC therapeutics at #ISCT2022. This is considered in a white paper that GAiT, ISCBI, CIRM, CT-TRACS and ISCT is developing based on the PSC Manufacturing Expert Panels held in LA.

Reply on Twitter 1522258567692177409 Retweet on Twitter 1522258567692177409 1 Like on Twitter 1522258567692177409 4 Twitter 1522258567692177409
Load More...

Invite Users to Site

Invite another user onto the GAiT Website
Invite Users

Social media

Follow us on social media

GAiT LinkedIn GAit Sound Cloud GAiT Twitter

 

 

Newsletter





© 2022 GAiT. All Rights reserved. Web Design by Conceptstore
  • Home
  • Portal Login